Citigroup
STAB

Citigroup’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Citigroup’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-50
Closed – – 7558
2016
Q1 		$0 Sell
50
-100
-67% -$337 ﹤0.01% 7874
2015
Q4 		$1K Buy
+150
New +$605 ﹤0.01% 7446
2015
Q3 		– Sell
-1,611
Closed -$7K – 7846
2015
Q2 		$7K Buy
+1,611
New +$4.85K ﹤0.01% 6646
2015
Q1 		– Sell
-18
Closed – – 7513
2014
Q4 		$0 Buy
+18
New +$141 ﹤0.01% 7395
2014
Q2 		– Sell
-605
Closed -$8K – 7380
2014
Q1 		$8K Buy
605
+488
+417% +$7.95K ﹤0.01% 6443
2013
Q4 		$3K Buy
117
+75
+179% +$2.04K ﹤0.01% 6731
2013
Q3 		$1K Sell
42
-50
-54% -$1.65K ﹤0.01% 6710
2013
Q2 		$3K Buy
+92
New +$3.17K ﹤0.01% 6472

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WA
Winfield Associates Cleveland, Ohio $276M AUM 15.18% 1-Year Est. Return

Citigroup's STAB Position: Q2 2016 in Review

Citigroup sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q2 2016, closing a stake of 50 shares.

Citigroup first reported a position in STAB in Q2 2013 and held it in 8 quarters. The position peaked at $8K in Q1 2014. 19 funds tracked by Wall St. Rank hold STAB as of Q2 2016.

  • Citigroup reported no remaining Statera Biopharma, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Citigroup sold 50 Statera Biopharma, Inc. Common Stock shares in Q2 2016.
  • Citigroup first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
  • Citigroup's Statera Biopharma, Inc. Common Stock position peaked at $8K in Q1 2014.
  • 19 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.